Oral delivery of Clostridium butyricum using selective antibacterial lipids for enhanced treatment of Fusobacterium nucleatum-associated intestinal diseases
Fecha de lanzamiento:
2025-06-01 Número de visitas: 29
Recomendación
Obtener una cotización gratuita
Language & Region Check
We detected that your visit originates from China.
Would you prefer to continue in Chinese?
This will switch to the Chinese-language model.
Your data will be processed according to local laws.